| American College of OB/GYN (ACOG)
|| May 5-9
|| San Diego, CA
| American Soc. Of Colo Rectal Surgeons (ASCRS)
|| June 2-6
|| San Antonio, TX
| (AWHONN) Association of Women's Health, Obstetric and Neonatal Nurses
|| June - 23-27
|| Washington, DC
Seprafilm® Adhesion Barrier is indicated for the reduction of post-surgical adhesions in patients undergoing abdominal or pelvic laparotomy.
Important Safety Information
Seprafilm should not be wrapped around an intestinal anastomosis as such usage may result in increased anastomotic leak related events, such as abscess or peritonitis. The safety and effectiveness of Seprafilm has not been established in combination with other adhesion prevention products and/or in surgical procedures not within the abdominopelvic cavity. The safety and effectiveness of Seprafilm has also not been evaluated in cases of pregnancy, malignancy, or frank infection. The type and frequency of adverse events reported are consistent with events typically seen following abdominopelvic surgery when used as directed.
Please see full prescribing information.